AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
3.730
-0.610 (-14.06%)
Feb 26, 2026, 4:00 PM EST - Market closed
AtaiBeckley Employees
AtaiBeckley had 54 employees as of December 31, 2024. The number of employees decreased by 29 or -34.94% compared to the previous year.
Employees
54
Change (1Y)
-29
Growth (1Y)
-34.94%
Revenue / Employee
$55,889
Profits / Employee
-$2,855,407
Market Cap
1.35B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 54 | -29 | -34.94% |
| Dec 31, 2023 | 83 | -50 | -37.59% |
| Dec 31, 2022 | 133 | 46 | 52.87% |
| Dec 31, 2021 | 87 | 52 | 148.57% |
| Mar 31, 2021 | 35 | - | - |
| Dec 31, 2020 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Novavax | 952 |
| Immunocore Holdings | 493 |
| Ardelyx | 489 |
| Intellia Therapeutics | 403 |
| Nurix Therapeutics | 317 |
| Harmony Biosciences Holdings | 268 |
| Biohaven | 256 |
ATAI News
- 13 hours ago - AtaiBeckley Touts Social Anxiety Breakthrough With Phase 2 Trial Data - Benzinga
- 16 hours ago - AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder - GlobeNewsWire
- 6 days ago - AtaiBeckley To Host Virtual Investor Day on March 6, 2026 - GlobeNewsWire
- 5 weeks ago - AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation - GlobeNewsWire
- 7 weeks ago - AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) - GlobeNewsWire
- 3 months ago - Enhanced Fortifies Executive Leadership Team & Board of Directors - PRNewsWire
- 3 months ago - Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript - Seeking Alpha